155 related articles for article (PubMed ID: 14675175)
1. Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.
Birklein F; Eisenbarth G; Erbguth F; Winterholler M
J Invest Dermatol; 2003 Dec; 121(6):1312-6. PubMed ID: 14675175
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
[TBL] [Abstract][Full Text] [Related]
3. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry.
Braune C; Erbguth F; Birklein F
Br J Dermatol; 2001 Jan; 144(1):111-7. PubMed ID: 11167691
[TBL] [Abstract][Full Text] [Related]
4. Somatotopic arrangement of sudomotor axon reflex sweating in humans.
Schlereth T; Brosda N; Birklein F
Auton Neurosci; 2005 Dec; 123(1-2):76-81. PubMed ID: 16194630
[TBL] [Abstract][Full Text] [Related]
5. Spreading of sudomotor axon reflexes in human skin.
Schlereth T; Brosda N; Birklein F
Neurology; 2005 Apr; 64(8):1417-21. PubMed ID: 15851733
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent anhidrotic effect of botulinum toxin.
Erbguth FJ
Curr Probl Dermatol; 2002; 30():131-40. PubMed ID: 12471707
[No Abstract] [Full Text] [Related]
7. Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations.
Rystedt A; Swartling C; Naver H
Acta Derm Venereol; 2008; 88(3):229-33. PubMed ID: 18480920
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
[TBL] [Abstract][Full Text] [Related]
9. Sudomotor testing predicts the presence of neutralizing botulinum A toxin antibodies.
Birklein F; Walther D; Bigalke H; Winterholler M; Erbguth F
Ann Neurol; 2002 Jul; 52(1):68-73. PubMed ID: 12112049
[TBL] [Abstract][Full Text] [Related]
10. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
Kreyden OP; Scheidegger EP
Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
12. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
Davarian S; Kalantari KK; Rezasoltani A; Rahimi A
Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
[TBL] [Abstract][Full Text] [Related]
13. Age- and sex-related differences in sudomotor function evaluated by the quantitative sudomotor axon reflex test (QSART) in healthy humans.
Lee JB; Lee IH; Shin YO; Min YK; Yang HM
Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):392-9. PubMed ID: 24684442
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
15. Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study.
Rystedt A; Karlqvist M; Bertilsson M; Naver H; Swartling C
Acta Derm Venereol; 2013 Nov; 93(6):674-8. PubMed ID: 23694974
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin--a possible new treatment for axillary hyperhidrosis.
Bushara KO; Park DM; Jones JC; Schutta HS
Clin Exp Dermatol; 1996 Jul; 21(4):276-8. PubMed ID: 8959898
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
Saadia D; Voustianiouk A; Wang AK; Kaufmann H
Neurology; 2001 Dec; 57(11):2095-9. PubMed ID: 11739832
[TBL] [Abstract][Full Text] [Related]
18. Six-Month Comparative Analysis Monitoring the Progression of the Largest Diameter of the Sweating Inhibition Halo of Different Botulinum Toxins Type-A.
da Costa A; Pereira ESP; de Oliveira Pereira M; Dos Santos FBC; Fávaro R; de Matos LS; Tannous TS; Duarte COP; Pereira CS
Aesthet Surg J; 2019 Aug; 39(9):993-1004. PubMed ID: 30107473
[TBL] [Abstract][Full Text] [Related]
19. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
20. [Axillary hyperhidrosis: successful treatment with botulinum toxin A].
Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
Hautarzt; 1998 Feb; 49(2):101-3. PubMed ID: 9551330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
